AT-Patch (ATP-C130/ATP-C70) vs QFR
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you need to continuously monitor a patient's cardiac activity for an extended period (up to 14 days) in an ambulatory setting to detect intermittent arrhythmias or evaluate treatment effectiveness. This tool is ideal for capturing elusive cardiac events that may not be apparent during a shorter in-clinic examination, providing high-accuracy data with integrated AI analysis for enhanced detection.
View AT-Patch (ATP-C130/ATP-C70) →Choose QFR if…
Choose QFR if you require AI-powered quantitative analysis of coronary vessel lesions directly from X-ray angiographic images to assess their functional significance. This software is best suited for cardiologists in the cath lab environment who need precise anatomical quantification and functional flow ratio (QFR) assessment to guide interventional decisions for coronary artery disease.
View QFR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | QFR |
|---|---|---|
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-premise (integrates into cath lab environment) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch offers superior usability due to its patient-centric design, including a compact, lightweight, and shower-proof wearable device that requires no charging during monitoring. The accompanying AT-Note smartphone app allows for live ECG viewing and easy symptom recording, enhancing the patient experience and clinician data collection.
Clinical Value
QFRBoth tools are FDA-cleared and provide significant clinical value. However, QFR offers a more transformative clinical impact by providing a non-invasive, AI-powered method to assess the functional significance of coronary lesions from X-ray angiographic images, which traditionally required invasive procedures like FFR. This innovation has shown excellent correlation with invasive FFR and improved outcomes in clinical studies.
Pricing & Value
TieNeither tool provides publicly available pricing information, making a direct comparison of their cost-effectiveness or overall value impossible. Both require direct contact with the company or distributors for quotes.
Enterprise Readiness
AT-Patch (ATP-C130/ATP-C70)Both tools are FDA-cleared and designed for on-premise deployment within medical institutions. However, AT-Patch explicitly states 'likely' HIPAA compliance and provides a dedicated 'Document Center' with user manuals and catalogues, indicating a more transparent and structured approach to enterprise deployment and support documentation.
Innovation
QFRWhile AT-Patch innovates in wearable ECG monitoring with AI and user-friendly features, QFR presents a more disruptive innovation. Its AI and deep learning algorithms enable non-invasive Quantitative Flow Ratio (QFR) assessment from standard angiographic images, potentially reducing the need for invasive functional assessments in interventional cardiology.
Support & Docs
AT-Patch (ATP-C130/ATP-C70)AT-Patch clearly provides a 'Document Center' on its website, offering readily accessible user manuals and catalogues for its device and software. In contrast, no specific support or documentation resources for the QFR medical device were found through web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | QFR |
|---|---|---|
| Tool Name | AT-Patch (ATP-C130/ATP-C70) | QFR |
| Company | ATsens Co. | QFR Solutions bv |
| Primary Function | Wearable ECG monitor for continuous cardiac monitoring and arrhythmia detection. | AI-powered medical software for visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments. |
| Key Technology | High-performance sensor chip for accurate ECG signal acquisition, AI/machine learning algorithms for ECG analysis. | AI-enabled end-diastolic frame selection, Deep learning for precise alignment of angiographic projections, Quantitative Flow Ratio (QFR) assessment. |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
| Specific Capability | Up to 14 days of continuous ECG monitoring (ATP-C130), live ECG viewing and symptom recording via smartphone app. | Quantitative Flow Ratio (QFR) assessment for functional significance, 3D reconstruction of coronary vessel models. |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and QFR.